T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma
Tamara Hilmenyuk, Carla A Ruckstuhl, Michael Hayoz, Christian Berchtold, Jean-Marc Nuoffer, Shyam Solanki, Hector C Keun, Paul A Beavis, Carsten Riether, Adrian F Ochsenbein
OncoImmunology | TAYLOR & FRANCIS INC | Published : 2018
We thank Andrea Huwiler for providing us with S1P, S1P Lyases and S1P receptor inhibitors as well for the determination of S1P levels in mouse serum and BCM by MS (Institute of Pharmacology, University of Bern); Thomas Kaufmann for providing us with QVD and other apoptosis inhibitors (Institute of Pharmacology, University of Bern) and Simon C. Robson for providing us CD39<SUP>-/-</SUP> mice (Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA). This work was supported by the Swiss National Science Foundation, the Swiss Cancer League, the Cancer League of the Canton of Bern, the Werner und Hedy Berger-Janser-Stiftung, the Bernese Foundation for Clinical Cancer Research and the Marlies Schwegler-Stiftung.